GlobeNewswire by notified

Press Release: Availability of the Q4 2022 Memorandum for modelling purposes

Share

Availability of the Q4 Memorandum for modelling purposes

Paris, France – January 4, 2023 - Sanofi announced today that its Q4 2022 Memorandum for modelling purposes is available on the "Investors" page of the company's website:

https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q4-results-2022

As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well as the foreign currency impact and share count. Sanofi's fourth-quarter 2022 results will be published on February 3, 2023.

About Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY

Media Relations
Sandrine Guendoul | + 33 6 25 09 14 25 | sandrine.guendoul@sanofi.com
Sally Bain | + 1 617 834 6026 | sally.bain@sanofi.com
Nicolas Obrist | + 33 06 77 21 27 55 | nicolas.obrist@sanofi.com
Victor Rouault | + 33 06 70 93 71 40 | victor.rouault@sanofi.com

Investor Relations
Eva Schaefer-Jansen | + 33 7 86 80 56 39 | eva.schaefer-jansen@sanofi.com
Arnaud Delépine | + 33 06 73 69 36 93 | arnaud.delepine@sanofi.com
Corentine Driancourt | + 33 06 40 56 92 | corentine.driancourt@sanofi.com
Felix Lauscher | + 1 908 612 7239 | felix.lauscher@sanofi.com
Priya Nanduri | + 1 617 764 6418 | priya.nanduri@sanofi.com

Nathalie Pham | + 33 07 85 93 30 17 | nathalie.pham@sanofi.com

Sanofi Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi’s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the  ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that COVID-19 will have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. Any material effect of COVID-19 on any of the foregoing could also adversely impact us. This situation is changing rapidly and additional impacts may arise of which we are not currently aware and may exacerbate other previously identified risks. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2021. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Arnar Már appointed deputy CEO of PLAY airlines2.5.2024 18:30:00 CEST | Press release

Arnar Már Magnússon has been appointed as the Deputy CEO of PLAY airlines. Arnar Már has served as the Chief Operations Officer of PLAY and will retain that position alongside his new role. "Being one of PLAY's founders, Arnar Már is a key figure within the company. His knowledge and years of experience in the flight industry will prove invaluable as we move forward. I am extremely grateful to have him by my side, and I am convinced his appointment will greatly benefit the airline," says Einar Örn Ólafsson, CEO of PLAY. "It has been a unique experience witnessing the growth of PLAY over the past years, and now we are in an excellent position to excel. I have proudly watched my colleagues at PLAY grow and prosper while establishing a brand-new airline. We now have a company with tremendous potential to reach greater heights. I am grateful for the level of trust placed in me with this new position and excited to further enhance PLAY's reputation alongside my colleagues," says Arnar Már M

FMC GlobalSat Acquires 100% of Anuvu’s Maritime, Enterprise and Government connectivity businesses2.5.2024 18:27:03 CEST | Press release

FORT LAUDERDALE, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- FMC GlobalSat ("FMC"), a leading provider of satellite and wireless connectivity solutions worldwide, proudly announces the successful acquisition of Anuvu’s Maritime, Enterprise, and Government connectivity businesses ("MEG"). Anuvu will retain ownership of its Maritime Entertainment business unit “MTN-TV”. Originally established as MTN Satellite Communications, Anuvu’s MEG businesses boast over three decades of expertise as a premier satellite network integrator. Renowned for its cutting-edge technology, engineering prowess, and numerous industry accolades, Anuvu has served as a trusted connectivity partner to nearly 4,000 terrestrial and maritime customer locations and millions of users across the globe. With headquarters in the US and operational bases in Brazil, Spain, and Norway, Anuvu’s unwavering commitment to excellence has earned it a distinguished reputation in the industry. FMC's acquisition not only expands its indust

KBC Group: Dividend Announcement2.5.2024 18:00:00 CEST | Press release

REGULATED INFORMATION KBC GROUP Naamloze Vennootschap (company with limited liability) Havenlaan 2 - 1080 Brussels VAT BE 0403.227.515 (RPL Brussels) www.kbc.com DIVIDEND ANNOUNCEMENT Communication of 2 May 2024 at 18:00 The Annual General Meeting of 2 May 2024 has decided to pay a gross dividend of 4.15 euros per share for the financial year ending on 31 December 2023. Further to the payment of an interim dividend in the sum of 1 euro per share on 15 November 2023, the gross final dividend will be 3.15 euros per dividend entitled share (2.205 euros after the deduction of 30% withholding tax). Relevant dates are: Ex-coupon date: 13 May 2024Record date: 14 May 2024Pay date: 15 May 2024 Attachment 20240502-dividend-en

Bonduelle - Quarter 3 FY 2023-2024 Revenue: Business activity slightly down on Quarter 3 in a climate of constrained consumption2.5.2024 18:00:00 CEST | Press release

BONDUELLE Head office: "La Woestyne" - 59173 Renescure - France Bonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 euros Registered under number : 447 250 044 (Dunkerque Commercial and Companies Register) Quarter 3 FY 2023-2024 Revenue Bonduelle Group: Business activity slightly down on Quarter 3 in a climate of constrained consumption The Bonduelle Group's revenue stands for Quarter 3 of FY 2023-2024 (from January 1, to March 31, 2024) at 564.9 million euros, thus a downturn compared with the previous fiscal year (572.2 million euros) of -1.3% on reported figures and -1.0% on a like-for-like basis*. No change in the scope of consolidation occurred over the period. Over the 9 first months, the revenue amounted to 1,778.0 million euros, down -2.1% on reported figures and up +2.8% on a like-for-like basis* after taking into account currency variations (significant depreciation of the ruble and weakening of the US dollar against the euro compared with

Eik fasteignafélag hf.: Interim results for the first three months of 20242.5.2024 17:56:42 CEST | Press release

The Interim Consolidated Financial Statements of Eik fasteignafélag hf. for the period 1 January to 31 March 2024 were approved by the Company’s Board of Directors and CEO on 2 May 2024 The main results are as follows: Income from operations amounted to ISK 2,709 million Thereof, rental income amounted to ISK 2,365 millionEBITDA amounted to ISK 1,700 millionTotal profit amounted to ISK 2,051 million.Net cash from operations amounted to ISK 1,011 million.The book value of investment properties amounted to ISK 135,656 million. The book value of assets for own use amounted to ISK 5,956 millionChange in value of investment properties amounted to ISK 2,734 million.Cash and cash equivalents amounted to ISK 1,623 million.Interest-bearing debt amounted to ISK 77,191 million.Equity ratio was 35.0%.Profit per share was ISK 0.6.Economic occupancy rate was 93.8%Weighted indexed interest was 3.33%.Weighted unindexed interest was 6.26%. Attached is an interim financial report which contains Interim

HiddenA line styled icon from Orion Icon Library.Eye